CHIEF: detecting cancer and predicting survival from slides
Trained on 15 million patches and 60,000 slides and tested on more than 19,400 slides from 32 datasets and 24 hospitals: it detects cancer with about 94% accuracy across 15 datasets, predicts mutations in 54 genes with over 70% accuracy, and improves survival prediction by 8% across 17 institutions. Retrospective validation; not trained on rare diseases or premalignant tissue.
Technology: CHIEF (pathology foundation model)
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: retrospective or benchmark
- Tested: Retrospective validation on more than 19,400 slides from 32 datasets at 24 hospitals; cancer detection was about 94% accurate across datasets.
- Still unknown: Validation beyond these datasets is still needed, rare and non-cancerous conditions and pre-malignant tissue were not tested, and gene prediction accuracy varies by gene and cancer type.
- AI role: Read digital tumor slides to detect cancer, predict gene mutations and survival, and generate heat maps of tissue features for pathologists.
Evidence sources: https://hms.harvard.edu/news/new-artificial-intelligence-tool-cancer
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: press release. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 685 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.